 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
' \% f& W) ?+ L" P6 b& Z 4 ?" k: m. `9 a9 E
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
e4 R# n8 k- ?( G% l) L ' k' M; P5 g0 J
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007% n, @* H! C& D+ c
$ d. W# t7 Y) k/ N
( e9 o: g! {. O+ u: o: I2 ~5 V
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.& `5 z! G5 O5 G. Q: S
. c- r, s! `$ d) u7 eThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
( y4 {' v4 D/ L* K& M8 P: Y% i- }# r/ X- @7 G& i! K
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
- d% T4 x0 J0 X9 }8 Y
6 ]# b% O) t' T# tIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
/ o: m p ^ M$ b" F8 S6 w/ ~ `$ v% g
4 ~4 K! n3 |6 s+ c1 H" `3 O3 NIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.- |, O# h' Z$ b9 m% P
( {; e7 C& p a* }7 o"As a scientist, it's one of the highlights of my CAREER," Shan said.4 d6 Y7 F" \* E! p( D" x
% d) `: e4 ]$ b8 O) X"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
. I( W0 Q' h- J; Q% p1 j2 b! y. i a$ c
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said., g' B1 y* z3 p8 E h* x
4 H1 F: b! ~( I1 U: T) J( A8 S+ p
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
$ k4 p6 ^7 P. y5 S6 k& h2 C. c% ]' t" ]5 ~$ n$ d8 `1 w
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
0 {- n$ S' @* q. B: B. p0 i* I! i L7 `8 ]& W8 q
. Y7 i1 c! N# R; phttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
8 P6 s# G$ P" s# D
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
